Therapy News and Research

RSS

Engineered red blood cell vesicles improve gene therapy delivery

Red blood cells serve as the foundation for nanocarriers that show promise in a new study as effective and efficient vehicles for gene therapy, tumor targeting and other medical treatments.

17 Aug 2026

Multi-source data-driven machine learning improves lung cancer care

Lung cancer remains one of the malignancies with the highest incidence and mortality worldwide.

17 Aug 2026

Engineered immune cells help eliminate severe bacterial infections effectively

Severe bacterial infections remain a major global health challenge because antibiotics alone often fail when the host immune system becomes dysfunctional.

17 Aug 2026

New genetic mutations linked to malaria drug resistance discovered

Researchers searching for genetic clues to the growing problem of malaria drug resistance identified new mutations associated with the parasite's decreased susceptibility to current treatment.

17 Aug 2026

Tagomics introduces LiquiPath, a first-in-class cfDNA-based blood test for multi-organ drug safety monitoring

Tagomics Ltd., a pioneering precision medicine company, today announced the launch of LiquiPath™, a cross-species, multi-organ "liquid pathology" platform, for non-invasive drug safety monitoring.

From Tagomics Ltd. 17 Aug 2026

Digital program proves effective for treating childhood anxiety symptoms

The follow-up of a randomized controlled trial shows that the internet-based Master Your Worries intervention program for treating children's anxiety has a long-term effect on the participants.

17 Aug 2026

Self-guided online compassion therapy may improve quality of life in chronic illness

A fully self-guided, internet-delivered attachment-based compassion therapy improved overall quality of life and reduced preoccupied attachment compared with a waiting-list control in adults with chronic medical conditions. The findings are preliminary, with high attrition, no active control, and most secondary psychological outcomes showing no significant between-group differences.

16 Aug 2026

Würzburg researchers discover alternative approach to preventing thrombosis

Glycoprotein VI, or GPVI for short, is a surface receptor found exclusively on platelets and their precursor cells, megakaryocytes in the bone marrow.

14 Aug 2026

Outfitting cells in "invisibility cloaks" could offer a novel approach to treating diabetes

Outfitting cells in "invisibility cloaks" may offer an easier, less damaging treatment pathway for people with diabetes undergoing cell therapy, according to researchers at Penn State.

14 Aug 2026

Expansion of pioneering robotic surgery training program announced

The Shelford Group has announced a major expansion of its pioneering Surgical Training in Advanced Robotic Technology (START) programme, extending accredited, platform-agnostic robotic surgery training to surgical trainees across the South East of England.

14 Aug 2026

Most Americans still believe outdated antibiotic guidance, study finds

"Always finish your antibiotics" is no longer considered medical best practice for all conditions.

13 Aug 2026

Ultrasound-guided SHIFTERS could expand CAR-T therapy for solid tumors

For more than a decade, CAR-T cell therapy has been one of the biggest breakthroughs in cancer medicine.

13 Aug 2026

Coral-inspired scaffold enhances bone repair by reprogramming immune cells

SONFH is one of the leading causes of non-traumatic osteonecrosis. Reported in up to 9%–40% of patients receiving prolonged or high-dose glucocorticoid therapy, the condition progressively weakens the femoral head and can eventually lead to joint collapse, making effective bone repair a major clinical challenge.

13 Aug 2026

Preoperative combination therapy improves head and neck cancer outcomes

Patients with head and neck cancer who received chemotherapy in addition to immunotherapy before surgery had a significantly reduced tumor size at the time of operation than patients who received immunotherapy alone.

13 Aug 2026

'Locked' cancer therapeutic safely shrinks breast tumors in mice

Although there are many cancer treatments available today that effectively eliminate abnormal cells, these therapies may also damage healthy cells, leading to unwanted side effects.

13 Aug 2026

Brain scans reveal neurological roots of sensory overload in kids

Overreactions to ordinary sensory stimuli - a scratchy shirt tag, a roaring vacuum cleaner, an unfamiliar smell - are commonly associated with autism.

13 Aug 2026

New ASTRO guidelines optimize radiation therapy for pancreatic cancer

An updated clinical guideline from the American Society for Radiation Oncology (ASTRO) provides evidence-based recommendations on the use of radiation therapy to treat adult patients with pancreatic cancer.

13 Aug 2026

Researchers identify genes that hinder CRISPR editing efficiency

Like a delivery driver navigating crowded city streets, a gene-therapy-toting lipid nanoparticle faces a gauntlet of potential detours on its journey toward a cell's nucleus.

13 Aug 2026

SynGenSys introduces expanded CHO.SET synthetic promoter library for enhanced biomanufacturing

SynGenSys, a biotechnology company designing synthetic gene promoter systems to address critical bottlenecks in biopharma manufacturing and enhance cell and gene therapy development, today announced the introduction of CHO.SET® 2.0. The expanded library of novel and patentable synthetic promoters is designed to improve protein production in CHO (Chinese Hamster Ovary) cells.

From SynGenSys Ltd. 13 Aug 2026

What is the optimal prostate-specific antigen cutoff to determine the success of prostate cancer treatment?

After treatment for metastatic prostate cancer, a drop in prostate-specific antigen (PSA) levels in the blood is an indicator that the treatment is working.

13 Aug 2026